University of Kansas School of Nursing, Kansas City 66160, USA.
Adv Exp Med Biol. 2010;678:55-69. doi: 10.1007/978-1-4419-6306-2_9.
No standard has been established for neuropsychologic testing to identify and quantify chemotherapy-related cognitive impairment (CRCI). A number of issues exist related to the complexity of the phenomenon and lack of correlation between standardized objective tests and subjective tests by patient self-report. Review of the issues related to current neuropsychologic tests used to evaluate CRCI provides support for qualitative examination of patients' lived experience in order to guide the development of more accurate tests.
目前尚未制定用于识别和量化化疗相关认知障碍（CRCI）的神经心理学测试标准。由于该现象的复杂性以及标准化客观测试与患者自我报告的主观测试之间缺乏相关性，存在许多问题。对用于评估 CRCI 的当前神经心理学测试相关问题的回顾为定性检查患者的生活体验提供了支持，以便指导更准确测试的开发。
